7
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 485-494 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Preparation and evaluation of solid lipid microspheres containing cyclosporine A. YANG, S. G., PARK, J. S., and CHOI, Y. W. Yakhak Hoechi, 1995, 39 (5), 487–494.
  • Rapid diffusion of the lipid phosphorus of phosphatidylglycerol liposomes through poly-carbonate membranes is caused by the oxidation of the unsaturated fatty acids. CHOW, C. Y., and HEATH, T. D. Biochim. Biophys. Acta, 1995, 1239 (2), 168–176.
  • A novel strategy affords high-yield coupling of antibody Fab' fragments to liposomes. SHAHINIAN, S., and SILVIUS, J. R. Biochim. Biophys. Acta, 1995, 1239 (2), 157–167.
  • Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. HANSEN, C. B., KAO, G. Y., MOASE, E. H., ZALIPSKY, S., and ALLEN, T. M. Biochim. Biophys. Acta, 1995, 1239 (2), 133–144.
  • Liposome-encapsulated silver sulfadiazine (SSD) for the topical treatment of infected burns: thermodynamics of drug encapulsulation and kinetics of drug release. LICHTENSTEIN, A. and MARGALIT, R. J. Inorg. Biochem., 1995, 60 (3), 187–198.
  • Protein properties affecting their entrapment and release characteristics from PLA/PLGA microspheres. REICH, G. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 546–547.
  • Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen. WHITE, W. I., CASSATT, D. R., MADSEN, J., BURKE, S. J., WOODS, R. M., WASSEF, N. M., ALvING, C. R., and KOENIG, S. Vaccine, 1995, 13 (12), 1111–1122.
  • The complementary particle-system: microcapsules, granulosomes, nanoparticles, and liposomes. SOLTUSZ, C., and BRUNKE, R. A. SOFW J., 1994, 120 (2/3), 81–82. 84, 86–87.
  • Removal of cadmium (II) ions by using Alkali Blue 6B attached poly (EGDMA-HEMA) microspheres. SALIN, B., DENIZLI, A., ENGIN, B., and PisKIN, E. React. Funct. Polym., 1995, 27 (3), 199–208.
  • Water proton relaxation studies of air-water distributions in beds of randomly packed monodisperse glass microspheres. SNAAR, J. E. M., and HILLS, B. P. Mol. Phys., 1995, 86 (5), 1137–1156.
  • Synthesis of magnetic polymer microspheres and application for immobilization of proteinase of Balillus sublitis. LI, X., and SUN, Z. y. Appl. Polym. Sci., 1995, 58(11), 1991–1997.
  • One-step preparation of double-walled microspheres. PEKAREK, K. J., JACOB, J. S., and MATHIOWITZ, E., Adv. Mater. (Weinheim, Ger), 1994, 6 (9), 684–687.
  • Syntheses and applications of large-size monodisperse polymer microspheres. CAO, T., DAI, B., and Dm, J., Gaofenzi Tongbao, 1995, (3), 174–180.
  • Ordered superstructure formation of core-shell type polymer microspheres. Ismzu, K. Macromol. Rep., 1995, A32 (Suppl. 5 & 6), 759–766.
  • Synthesis of poly(vinyl alcohol) core-polystyrene shell type microspheres. SAITO, R., OKAMURA, S., and Ismzu, K. Polymer, 1995, 36 (23), 4515–4520.
  • Functionalization of polymer microsphere surface by plasma treatment. HARAGUCHI, T., YAMADA, K., IDE, S., HATANAKA, C., IJICHI, K., HATATE, Y., and KAJIYAMA, T. Kitakyushu Kogyo Koto Senmon Gakko Kenkyu Hokoku, 1994, 27, 65–70.
  • Preparation of reactive crosslinked polymer microspheres by the emulsion polymerization of allyl methacrylate. MATSUMOTO, A., MORI, Y., TAKAHASHI, S., and AOTA, H. Netsu Kokasei jushi, 1995, 16 (3), 131–143.
  • Adsorption of monomers on microspherical structures of thermal heterocomplexes mol-ecules from amino acids. HONDA, H., SAKURAZAWA, S., KIMURA, H., Imm, E., and MATSUNO, K. Origins Life Evol. Biosphere, 1995, 25 (5), 443–455.
  • Lanthanide cleavage of phosphodiester liposomes. Moss, R. A., PARK, B. D., SCRIMIN, P., and GHIRLANDA, G. J. Chem. Soc., Chem. Commun., 1995, (16), 1627–1628.
  • The influence of single-chain-anchored galactose on the polymorphism of resuspended lyophilized dipalmitoylphosphatidylcholine liposomes. FOERSTER, G., DE LA CRUZ, R. 0., BENDAS, G., and NAHN, P., Prog. Colloid. Polym. Sci., 1995, 98, 201–205.
  • Synthesis of novel galactosyl ligands from liposomes and the influence of the spacer on accumulation in the rat liver. SASAKI, A., MURAHASHI, N., YAMADA, H., and MORIKAWA, A. Bio. Pharm. Bull., 1995, 18 (5), 740–746.
  • Nonphospholipid liposomes: properties and potential use in flavor encapsulation. MATHUR, R., and CAPASSO, P. ACS Symp. Ser., 1995, 610, 219–230. 0025-2048/96 $12.00 © 1996 Taylor & Francis Ltd.
  • Phospholipid liposomes: properties and potential use in flavor encapsulation. WEINER, N. ACS Symp. Ser., 1995, 610, 210–218.
  • Characterization of free, and alginate-polylysine-alginate microencapsulated Erwinia herbicola for the conversion of ammonia, pyruvate,, and phenol into L-tyrosine. LLOYD, G. I., and CHANG, T. NI. S., Biotechnol. Bioeng., 1995, 48 (6), 706–714.
  • Introduction of murine 11-4 gene into B16(F10) melanoma tumors by direct gene transfer with DNA-liposome complexes. NIissoL, E., SOCHANIK, A., and SZALA, S., Cancer Lett. (Shannon, Irel), 1995, 97(2), 189–193.
  • A chlorine channel from human placenta reconstituted into giant liposomes. RIQUELME, G., STITZIN, A., B.Aaaos, L. F., and LIBERONA, J. L. Am. y. Obstet. Gynecol., 1995, 173 (3, Pt. 1), 733–738.
  • Effects of free and liposome-encapsulated antibiotics on adherence of Pseudomonas aeruginosa to collagen type I. TRAFNY, E. A., STEPINSKA, M., ANTOS, NI., and GRZYBOWSKI, J. Antimicrob. Agents Chemother., 1995, 39 (12), 2645–2649.
  • Fatty acyl-CoA:sphingosine acyltransferase in bovine brain mitochondria: its solubilization and reconstitution onto the membrane lipid liposomes. SHIMENO, H., SOEDA, S., YASUKOUCHI, M., OKAMURA, N., and NAGANIATSU, A. Biol. Pharm. Bull., 1995, 18 (10), 1335–1339.
  • Effects of various amino acids on membrane characteristics of liposomes. IsmNomoat, T., OGINO, K., SAKAI, H., FUNADA, T., MASUZAWA, NI., and ABE, Ni. Yukagaku, 1995, 44 (11), 985–990.
  • Fusion of negatively charged liposomes by synthetic N-terminal fragments of HIV trans-membrane protein. TERLETSKAYA, Y. T., TRIKASH, I. 0., SERDYUK, E. S., and ANDREEV, S. NI. Biokhimiya (Moscow), 1995, 60 (10), 1711–1719.
  • Comparison of the antioxidative effectiveness of a-tocopherol and caffeic acid during bulk phase and liposome oxidation of acylglycerols with a high linoleic acid con-tent. YANISHLIEVA, N. V., MAREKOV, I. N., and CHRISTIE, W. W. SOFW y., 1994, 120 (11), 662–665.
  • Efficacy of liposome encapsulated triethylenetetramine hexaacetic acid (TTHA) against cadmium intoxication: role of lipid composition. BEFIARI, J. R. Ind. Health, 1995, 33 (2), 83–88.
  • Catecholamine-containing biodegradable microsphere implants: an overview of experi-mental studies in dopamine-lesioned rats. NIcRAE, A., DAHLSTROEM, A., HJOR'FH, S., LING, E. A., NIAsoN, D. and Tice, T. Adv. Behav. Biol., 1995, 44421–427.
  • In vitro liposome-mediated DNA transfection of epithelial cell lines using the cationic liposome DC-Chol/DOPE. CAPLEN, N. J., KINRADE, E., SORGI, F., GAO, X., GRUENERT, D., GEDDES, D., COUTELLE, C., HUANG, L., ALTON, E. W. F. W., and WILLIAMSON, R. Gene Ther., 1995, 2 (9), 603–613.
  • Antitumor activity of doxorubicin encapsulated in poly(ethylene glycol)-coated liposomes. Hosoax, J., UNEZAKI, S., MARUYANIA, K., TSUCHIYA, S., IWATSURU, M. Biol. Pharm. Bull., 1995, 18 (9), 1234–1237.
  • Development of 5-fluorouracil incorporated in microspheres for peritoneal carcinomatosis-animal experiments. HAGIWARA, A., TAKAHASHI, T., SHIMOTSUMA, M., SHIR.ASU, NI., TSUJIMOTO, H., 01IYAMA, T., OHGAKI, NI., IMANISHI, T., YAMAZAKI, J., et al. Gan to Kagaku Ryoho, 1995, 22 (11), 1638–1640.
  • Antitumor effects of liposome-entrapped carboplatin (Lipo-CBDCA) after intraperitoneal administration in rats bearing carcinomatous peritonitis. Mizuxo, I., YASUI, T., TAKEYAMA, H., ISHIKAWA, NI., TERADA, J., Mona, N., UEDA, T., SUMITA, N., KOBAYASHI, K. et al. Gan to Kagaku Ryoho, 1995, 22(11), 1598–1601.
  • Experimental study on cisplatin microspheres incorporated in polylactic acid and poly-ethylene glycol acid. TOKUDA, K., NATSUGOE, S., KUNIANOHOSO, T., SHAMIDA, NI., YOSHIZAWA, H., HATATE, Y., NAKAMURA, K., Y.ANIADA, K., NEDACHI, NI., and AIKO, T. Gan to Kagaku Ryoho, 1995, 22 (11), 1641–1643.
  • Effect of particle size on colloid stability of bilayer-covered polystyrene microspheres. TSURUTA, L. R., LESSA, NI. NI., and CARMONA, R. A. NI. Y. Colloid Interface Sci., 1995, 175 (2), 470–475.
  • An experimental investigation on the structure of microcapsules. DOBASHI, T., YEH, F., YING, Q., ICHIKAWA, K., and Cm:, B. Langmuir, 1995, 11(11), 4278–4282.
  • Preparation and characterization of monoparticulate layers composed of partially hydro-phobic glass and silica particles: a Langmuir film balance study. I. Monoparticulate layers composed of microspheres. HORVOLGYI, Z., NEMETH, S., and FENDLER, J. H., Magy. Kern. Foly., 1995, 101 (11), 488–497.
  • Classical model for energy transfer in microspherical droplets. PINEDA, A. C., and Roms, D. Phys. Rev. E: Stat. Phys., Plasmas, Fluids, Relat. Interdiscip. Top., 1995, 52 (5-B), 5178–5194.
  • Production of water-containing polymer microcapsules by the complex emulsion/solvent evaporation technique. Effect of process variables on the microcapsule size distribution. KENTEPOZIDOU, A., and KIPARISSIDES, C..7. Microencapsulation, 1995, 12 (6), 627–638.
  • Peptide attachment to extremities of liposomal surface grafted PEG chains: preparation of the long-circulating form of laminin pentapeptide, YIGSR. ZALIPSKY, S., PUNTAMBEKAR, B., BOULIKAS, P., ENGBERS, C. M., and WOODLE, M. C. Bioconjugate Chem., 1995, 6(6), 705–708.
  • Delivery of IL-1 microspheres to tumor macrophages. MULLERAD, J., APTE, R. N., and COHEN, S. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 512–513.
  • Propranolol loaded silicone microspheres: preparation by emulsion-polymerization and in-vitro release rates. MAINCENT, P., DARME, X., KEDZIEREWICZ, F., HOFFMAN, M., ETIENNE, A., and LEIMUT, J. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 432–433.
  • Development of new chitosan-gelatin microcapsules produced by a complex coacervation process. REMUNAN, L. C., ALONSO, M. J., CALLEJA, T., VILA, J. J. L., and BODNIEIER, R. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 430–431.
  • Comparative physicochemical study between two types of sterically stabilized liposomes. KOSTARELOS, K., LUCKHAM, P. F., and TADROS, T. F. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 410–411.
  • The use of methyl ethyl ketone as a solvent for the preparation of PLGA microcapsules. SAH, H., SMITH, M. S., and CHERN, R. T. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 408–409.
  • Lectin-bearing polymerized liposomes as potential oral vaccine carriers. CHEN, H., TORCHI LIN, V., ELDRIDGE, J., and LANCER, R. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 204–205.
  • Stabilization of liposome with blood compatible water-soluble phospholipid polymer. ISHIHARA, K., TSUJINO, R., HAMADA, M., and NAKABAYASHI, N. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 188–189.
  • Transdermal iontophoretic delivery of enkephalin formulated in liposomes. VUTLA, N. B., BETAGERI, G. V., and BANGA, A. K. J. Pharm. Sci., 1996, 85 (1), 5–8.
  • Plug and seal: prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin liposomes. KHAW, B. A., TORCHILIN, V. P., VURAL, I., and NARULA, J. Nat. Med. (N Y), 1995, 1(11), 1195–1198.
  • Gelatin microspheres combined with hydrophilic polymers: in vivo and in vitro determination of bioadhesive properties. PREDA, M., VLADUT, C., and LEUCUTA, S. E. Farmacia (Bucharest), 1995, 43 (1-2), 51–59.
  • Stability of phosphoinositides containing liposomes: effects of Triton X-100, temperature and 68 RPM. RIAZ, M., and WEINER, N. Pak. y. Pharm. Sci., 1994, 7(2), 61–68.
  • In vitro release of huGM-CSF from esterified hyaluronic acid microspheres. NIGHTLINGER, N. S., BENEDETTI, L., SORANZO, C., PETTIT, D. K., PANKEY, S. C., and GOMBOTZ, W. R., Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 738–739.
  • In vitro release of bioactive recombinant human interferon-y from PLGA microspheres. CLELAND, J. L., and YANG, J. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 518–519.
  • Development of a new in vitro release method for microencapsulated proteins. DUENAS, E. T., YANG, J., JONES, A. J. S., and CLELAND, J. L. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 516–517.
  • Development of stable protein formulations for microencapsulation in biodegradable poly-mers. CLELAND, J. L., and JONES, A. J. S. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 514–515.
  • Improved targeting and therapeutic efficacy of cefazolin encapsulated in liposomes against S. aureus in mouse infection model. LIANG, D., WHITE, C. A., and CHOW, D. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 448–449.
  • The effects of lipid concentration on the nebulization of liposomes. BRIDGES, P. A., TAYLOR, K. M. G., and MCCALLION, 0. N. M. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 440–441.
  • Novel liposome based systems for the protection of photolabile drugs. LOUKAS, Y. L., AND GREGORIADIS, G. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 438–439.
  • Pilocarpine bioavailability from microspheres ophthalmic drug delivery system. DESHPANDE, S. G., and RATHOD, S. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 406–407.
  • The influence of Eudragit microencapsulation on the hydrolysis kinetics of acetylsalicylic acid. VACHON, M. G., and NAIRN, J. G. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 274–275.
  • "Drugs in cyclodextrins in liposomes": Evaluation of the concept in vivo. MCCORMACK, B., and GREGORIADIS, G. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 190–191.
  • The influence on skin penetration by dithranol formulated in phospholipid solutions and phospholipid liposomes. GEHRING, W., GHYCZY, M., GAREISS, J., and GLOOR, M. Fur. J. Pharm. Biopharm., 1995, 41(2), 140–142.
  • Biopharmaceutical evaluation of microencapsulated ion-exchange resins containing diclo-fenac. TORRES, D., GARCIA, E. G., SEM, B., and VILA, J. J. Fur. y. Pharm. Biopharm., 1995, 41(2), 127–131.
  • Preliminary assessment of a microencapsulated polyvalent oral vaccine against entero-toxigenic E. COIL JEYANTHI, R., KODAK, J., HAMONT, J. V., CASSELS, F., MCQUEEN, C. E., and REID, R. H., Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 276–277.
  • Polymers for forming drug-loaded microspheres: natural versus synthetic. THIES, C. Mater. Res. Soc. Symp. Proc., 1995, 394, 49–54.
  • Sterically stabilized liposome therapeutics. WOODLE, M. C. Adv. Drug Delivery Rev., 1995, 16 (2, 3), 249–266.
  • Interaction of PEG-phospholipid conjugates with phospholipid: implications in liposomal drug delivery. BEDU, A. F. K., and HUANG, L. Adv. Drug Delivery Rev., 1995, 16 (2, 3), 235–247.
  • Pharmacokinetic studies on the drug delivery system using liposomes. HARASHIMA, H. Yakubutsu Dotai, 1995, 10 (4), 566–575.
  • The "Stealth" liposome: a prototypical biomaterial. LASIC, D. D., and NEEDHAM, D. Chem. Rev. (Washington, DC), 1995, 95 (8), 2601–2628.
  • Determination of membrane thickness of microcapsules and its influence on release velocity. LIMING, Z., YANG, D., and WANG, J. Zhongguo Fangzhi Daxue Xuebao, 1995, 21 (2), 22–31.
  • Structure of an acidic microcapsular glycan from the reference strain (C.D.C. 866-57) for Serratia marcescens serogroup 01. JOHANSSON, A., WIDMALM, G., JANSSON, P. E., and WILKINSON, S. G. Carbohydr. Res., 1995, 270 (2), 191–199.
  • Liposomes prepared from 2-(bis-(2-hexacosa-10,12-diynoloxyethyl)amino)ethanesulfonic acid. HOLTZAPPLE, M. T., VANDUKER, F. C. JR., NAM, K. Y., and LALOND, J. J. Org. Prep. Proced. Int., 1995, 27 (4), 507–510.
  • Permeability change of liposomal membrane induced by interleukin-la. OKU, N., SAITO, N., OKADA, S., WATANABE, N., KOBAYASHI, Y. j. Biochem. (Tokyo), 1995, 118 (4), 832–835.
  • Influence of liposomes rich in unsaturated or saturated fatty acids on the growth of human xenotransplanted mammary carcinomas and on the levels of heart type fatty acid binding protein. NAUNDORF, H., ZSCFIIESCHE, W., RESZKA, R., and FICHTNER, I. In Vivo, 1995, 9(3), 247–251.
  • Incorporation, release and in vitro antibacterial activity of liposomal aminoglycosides against Pseudomonas aeruginosa. OMRI, A., RAVAOARINORO, M., and POISSON, M. J. Antimicrob. Chemother., 1995, 36 (4), 631–639.
  • Continuous hybridoma culture in a low-protein serum-free medium supplemented with liposomes. MARTIAL, A., GAILLARD, I., ENGASSER, J. M., and MARC, A. Enzyme Microb. Technol., 1995, 17 (12), 1062–1066.
  • Intraduodenal immunization with microencapsulated CFA/II induces a delayed, anti-CFA/II, IgG antibody-secreting spleen cell response. SAC, K., REID„ R. H., IVIcQueEN, C., BOEDEKER, E. C., NELLORE, R., DALAL, P., and BHAGAT, H. R. Adv. Exp. Med. Biol., 1995, 371B, 1469–1474.
  • Regulation of neutral cholesterol esterase activity by phospholipids containing negative charges in substrate liposome. ISHII, I., ONOZAKI, R., TAKAHASHI, E., TAKAHASHI, S., FUJIO, N., HARADA, T., NIoals.Aki, N., SHIRAI, K., SAITO, Y., and HIROSE, S. 5. Lipid Res., 1995, 36 (11), 2303–2310.
  • In vitro antifungal activity of liposome-encapsulated nystatin. EL DIN., M. M. E., and ABU, Z. S. S. Afr. y. Mycol. Biotechnol., 1994, 2 (3), 251–259.
  • Calorimetric investigations on peptide-modified liposomes. DOERFLER, H. D., GOERNER, G., and BENDZKO, P. Pharmazie, 1995, 50 (8), 553–557.
  • Systemic toxicology and laser safety of laser targeted angiography with heat sensitive liposomes. ASRANI, S., D'ANNA-S., ALKAN, 0. H., WANG, W., GOODMAN, D., and ZEIMER, R. 5. Ocul. Pharmacol. Ther., 1995, 11(4), 575–584.
  • Assessment of coronary vasodilator reserve by N-13 ammonia PET using the microsphere method and Patlak plot analysis14. TADAMURA, E., TANIAKI, N., YONEKURA, Y., KLIO0H, T., NIAGATA, Y., TORIZUKA, T., TATENO, NI., NOHARA, R., SASAYAMA, S., and KONISHI, J. Ann. Nucl., TIed., 1995, 9 (3), 109–118.
  • Magnetic resonance imaging of lymph nodes with Gd-containing liposomes. ToecHiLin, V. P., TRUBETSKOY, V. S., and WOLF, G. L. Handb. Targeted Delivery Imaging Agents, CRC, Boca Raton, Fla, 1995, 403–413.
  • Targeted delivery of imaging agents by liposomes. PHILLIPS, W. T., and GOINS, B. Handb. Targeted Imaging Agents, CRC, Boca Raton, Ha, 1995, 149–173.
  • Protective effect of phosphatidylcholine liposomes during hemorrhagic shock in cats. KRYZHZANOVSKII, G. N., LESKOV.A, G. F., UDOVICHENKO, V. I., and KULIKOVA, 0. S. Byull. Eksp. Biol. Med., 1995, 119 (5), 480–484.
  • Heat-mediated selective delivery of liposome-associated melphalan in murine melanoma. CHELVI, HELVI. T., JAIN, S. K., and RALFIAN, R. Melanoma Res., 1995, 5 (5), 321–326.
  • Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and thera-peutic properties of vincristine in murine and human tumor models. WEBB, M. S., HARASYM, ARASYM. 0., MASIN, D., BALLY, M. B., and MAYER, L. D. Br. J. Cancer, 1995, 72 (4), 896–904.
  • Soluble intercellular adhesion molecule-1 and serum cytokines in melanoma patients treated with liposomes containing muramyl tripeptide. FAVARO, D., SANTAROSA, M., QUAIA, M., SPADA, A., FRESCHI, A., TALAMIN, R., and GALLIGIONI, E. Tumori, 1995, 81 (3), 185–190.
  • Formulation and antitumor efficacy of liposomal-caprylated-TNE-SAM2. AKIMARU, K., AUZENNE, E., AmmAau, Y., LEROUX, M. E., HAYMAN, A. C., UTSUMI, T., SOMA, G. I., and KLOSTERGAARD, J. Cytokines Mol. Ther., 1995, 1 (3), 197–210.
  • Modulation of daunorubicin intracellular accumulation in P-glycoprotein expressing MCF-7 human breast adenocarcinoma cells by thermosensitive-liposome encapsulation and hyperthermia. IVIERLIN, J. L., MARCHAL, S., RAMACCI, C., NO'TTER, D., and VIGNERON, C. Int. J. Hyperthermia., 1995, 11(6), 855–865.
  • New organic monosized microspheres for use in enantiomer separations by high-performance liquid chromatography. SINIBALDI, M., CASTELLANI, L., FEDERICI, F., MESSINA, A., GIRELLI, A. M., LENTINI, A., and TESAROVA, E., J. Liq. Chromatogr., 1995, 18 (16), 3187–3203.
  • Singlet oxygen generation from liposomes: a comparison of time-resolved 1270 nm emission with singlet-oxygen kinetics calculated from a one dimensional model of singlet-oxygen diffusion and quenching. Fu, Y., and KANOFSKY, J. R., Photochem. Photobiol., 1995, 62 (4), 692–702.
  • Gamma-irradiation of non-frozen, frozen, and freeze-dried liposomes. ZUIDAM, N. J., LEE, S. S. L., and CROMMELIN, D. J. A. Pharm. Res., 1995, 12 (11), 1761–1768.
  • Antinociception and side effects of L- and D-dipalmitoylphosphatidyl choline liposome-encapsulated alfentanil after spinal delivery in rats. ISACKSON, J., WALLACE, M. S., Ho, R. J. Y., SHEN, D. D., and YAKSH, T. L. Pharmacol. Toxicol. (Copenhagen), 1995, 77 (5), 333–340.
  • Enhanced therapeutic effect of cytidine-5'-diphosphate choline when associated with GM1 containing small liposomes as demonstrated in a rat ischemia model. FRESTA, M., WEHRLI, E., and PUGLIS, G. Pharm. Res., 1995, 12 (11), 1769–1774.
  • pH lowering in liposomal dispersions induced by phospholipid peroxidation. ARAKANE, K., HAYASHI, K., NAITO, N., NAGANO, T., and HIROBE, M. Chem. Pharm. Bull., 1995, 43 (10), 1755–1758.
  • Alkyl chain length dependency in hydrolysis of liposomal phosphatidylcholine by dialkyl phosphate. HAYASHI, K., ARAKANE, K., NAITO, N., NAGANO, T., and HIROBE, M. Chem. Pharm. Bull., 1995, 43 (10), 1751–1754.
  • Specific hybrid liposomes composed of phosphatidylcholine and polyoxyethylenealkyl ether with markedly enhanced inhibitory effects on the growth of tumor cells in vitro. MATSUMOTO, Y., IMAMURA, C., ITO, T., TANIGUCHI, C., and UEOKA, R. Biol. Pharm. Bull., 1995, 18 (10), 1456–1458.
  • Sterically stabilized amphotericin B liposomes: toxicity and biodistribution in mice. VAN ETTEN, E. W. M., VIANEN, W. V., TIJHUIS, R. H. G., STORM, G., and BAKKER WOUDENBERG, I. A. J. M. J. Controlled Release, 1995, 37 (1-2), 123–129.
  • Preparation and degradation of surfactant-free PLAGA microspheres. CARRIO, A., SCHWACH, G., COUDANE, J., and VERY, M. J. Controlled Release, 1995, 37 (1-2), 113–121.
  • Solubilization of unilamellar liposomes caused by quaternary ammonium surfactants. DE LA MAZA, A., and PARRA, J. L. J. Controlled Release, 1995, 37 (1-2), 33–42.
  • Effect of process variables on the in vitro degradation of protein microspheres. MAGEE, G. A., HALBERT, G. W., and WiLmorr, N. y. Controlled Release, 1995, 37 (1-2), 11–19.
  • Study on liposomes with prolonged circulation times. ZHANG, J. M., YANG, H., and Hou, X. P. Shengwu Huaxue Zazhi, 1995, 11(5), 615–618.
  • The effects of formulation of PLA microspheres on immune responses: an in vivo study. ALPAR, H. 0., CONWAY, B. R., and BOWEN, J. C. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 564–565.
  • Thermodynamic strategy to optimize protein encapsulation into PLA microspheres. JOHANSEN, P., NAM, T. H., MERKLE, H. P., and GANDER, B. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 474–475.
  • Interactions of DNA with cationic liposome of differing compositions. SORGI, F. L., and HUANG, L. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 460–461.
  • Effects of membrane fluidity and the glucoside chain length on lyophilization of liposomes. MIYAJIMA, K., and SUZUKI, T. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 458–459.
  • Physicochemical and disposition characteristics of plasmid DNA complexed with cationic liposomes. MAHATO, R. I., YOSHIDA, M., NOMURA, T., KAWABATA, K., TAKAKURA, Y., and HASHIDA, M. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 418–419.
  • In vitro degradation of double-walled polymer microspheres. PEKAREK, K. J., FERRER, K., DYRUD, NI. J., and MATHIOWITZ, E. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 390–391.
  • Release of ketoprofen from microspheres of poly(2-hydroxyethyl methacrylate) or poly(2-hydroxyethyl methacrylate)-co-fl-methacryloyloxyethyl deoxycholate crosslinked with ethylene glycol dimethacrylate and tetraethylene glycol dimethacrylate. ORIENTI, 1,, GIANASI, E., ZECCHI, V., and CONTE, U. Eur. y. Pharrn. Biopharm., 1995, 41(4), 247–253.
  • Engineering liposomes for drug delivery: progress and problems. GREGORIADIS, G. Trends Biotechnol., 1995, 13 (12), 527–537.
  • Drug targeting by magnetically responsive microspheres. CHOPRA, K. S., and SINGLA, D. East. Pharm., 1994, 37 (440), 79–82.
  • The mechanical properties of an aluminum composite reinforced with alumina microspheres. FURUKAWA, M., WANG, J., HORITA, Z., NEMOTO, M., MA, Y., and LANGDON, T. G. Key Eng. Mater., 1995, 104–107 (Metal Matrix Composites, Pt. 2), 817–824.
  • Effect of ceramic microspheres on the microstructure of eutectic Al-Si composites. SETARGEW, N., PARKER, B. A., and COUPER, M. J. Mater. Sci. Forum, 1995, 189–190 (Interfaces II), 297–302.
  • Study of battery anode of copper-microencapsulated hydrogen-storage alloy. WEN, Z., Li, G., HUANG, A., QIAO, H., MA, S., and SHEN, J. Dianyuan lishu, 1995, 19 (3), 24–27.
  • Catalytic activity of Ni-Mo sulfide supported on a particular carbon black of hollow micro-sphere in the liquefaction of a subbituminous coal. SAK.ANISHI, K., HASUO, H., KISHINO, M., .MOCHIDA, I., and OKUNIA, 0. Energy Fuels, 1996, 10 (1), 216–219.
  • Preparation and characterization of dipalmitoylphosphatidylcholine liposomes containing interleukin-2. FLEURY, L., OLLIVON, M., DUBOIS, J. L., PUISIEUX, F., and BARRATT, G. Braz. Med. Biol. Res., 1995, 28 (5), 519–529.
  • Liposomal vaccines: clinical status and immunological presentation for humoral and cellular immunity. ALvING, C. R. Ann. N. Y. Acad. Sci., 1995, 754,143–152.
  • Membrane fusion between Ehrlich ascites of mastocarcinoma cells and liposomes induced by proton translocation of trans-plasma membrane NADH-ferricyanide redox enzymes. Liu, S., Wu, J., and Li, Q. Shiyan Shengwu Xuebao, 1995, 28 (2), 137–145.
  • Lung annexin II promotes fusion of isolated lamellar bodies with liposomes. Liu, L., FISHER, A. B., and ZININIERNIAN, U. J. P. Biochim. Biophys. Acta, 1995, 1259 (2), 166–172.
  • The significance of membrane lipids in exocytosis: control of liposome-evoked amylase release from secretory granules isolated from the rat parotid gland. MIZHNO, K. M., INoKuctii, H., KAMEYAMA, Y., YASHIRO, K., SHIN, S. 0., and FUJITA, A..7. Biochem. (Tokyo), 1995, 118 (4), 693–699.
  • The plasma membrane H +-ATPase from higher plants: functional reconstitution into liposomes and its regulation by phospholipds. KASANIO, K., and SAKAKIBARA, Y. Plant Sci. (Shannon, Ire), 1995, 111 (2), 117–131.
  • Polymeric microcapsule arrays. MARTIN, C. R., and PARTHASARATHY, R. V. Adv. Mater. (Weinheim, Ger), 1995, 7 (5), 487–488.
  • Physical (in)stability of liposomes upon chemical hydrolysis: the role of lysophospholipids and fatty acids. ZUIDANI, N. J., Gouw, H. K. M. E., BARENHOLZ, Y., and CROMMELIN, D. J. A. Biochim. Biophys. .Acta, 1995, 1240 (1), 101–110.
  • EPR study of spermine interaction with multilamellar phosphatidylcholine liposomes. MONIO, F., WISNIEWSKA, A., and STEVANATO, R. Biochim. Biophys. Acta, 1995, 1240 (1), 89–94.
  • Lipids-liposomes—biological membranes. BANDOROWICZ, P. J. Postepy Biochem., 1995, 41 (2), 149–150.
  • Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. RUBBO, H., PARTHASARATHY, S., BARNES, S., KIRK, M., KALYAN.ARANIAN, B., and FREEMAN, B. A. Arch. Biochem. Biophys., 1995, 324 (1), 15–25.
  • Polymerase chain reaction in liposomes. OBERHOLZER, T., ALBRIZIO, M., and Luisi, P. L. Chem. Biol., 1995, 2 (10), 677–682.
  • Hyperinsulinemia in rats with alloxan diabetes after oral administration of insulin-containing negatively charged liposomes. AKHREM, A. A., VOROBYOV, NI. S., KOSEL, M. A., TSYBOVSKY, I. S., ZABOROVSKAYA, Z. V., and KHOLODOVA, Y. A., Probl. Endokrinol., 1995, 41 (1), 37–39.
  • Anesthesia with propanidid in liposomal preparations. An experimental study in pigs. KLOCKGETHER, R. A., KERSTEN, J., SCHROEDER, T., STAFFORST, D., KETTLER, D., and HELLIGE, G. Anaesthesist, 1995, 44 (8), 573–580.
  • Prevention of phorbol myristate acetate-induced acute lung injury by a-tocopherol liposomes. SUNTRES, Z. E., and SHEK, P. N..7. Drug Targeting, 1995, 3 (3), 201–208.
  • Cardiovascular effects of the microsphere suspending agent, Tween 80, in pigs. GRUND, F., SOMMERSCHILD, H. T., KIRKEBOEN, K. A., and ILEBEKK, A. Acta Physiol. Scand., 1995, 155 (3), 331–332.
  • Intra-arterial liposomal adriamycin for metastatic adenocarcinoma of the liver. KONNO, H., MAauo, Y., MATSUDA, I., NAKAMURA, S., and BABA, S. Eur. Surg. Res., 1995, 27 (5), 301–306.
  • pH-responsive gelatin microspheres for oral delivery of anticancer drug methotrexate. NARAYANI, R., and RAO, K. P., J. Appl. Polym. Sci., 1995, 58 (10), 1761–1769.
  • Evaluation of an aliphatic polyurethane as a microsphere matrix for sustained theophylline delivery. SUBHAGA, C. S., RAVI, K. G., SUNNY, M. C., and JAYAKRISHNAN, A. y. micromosulation, 1995, 12 (6), 617–625.
  • Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy. MCLAUGHLAN, G., DAVIDSON, D. J., STEVENSON, B. J., DICKINSON, P., DAVIDSON-SMITH, H., DORIN, J. R., and Poamous, D. J. Gene Ther., 1995, 2 (9), 614–622.
  • Levonorgestrel loaded biodegradable microspheres: effect of drug loading and polymer composition on in-vitro release kinetics. BIIALLA, H. L., and DOSHI, C. C. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 774–775.
  • Characterization of indomethacin-loaded microspheres. RICHEY, T., and HARRIS, F. W. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 416–417.
  • Controlled release of liposomes—a new approach for controlling the presentation of liposomal antigens. MACHLUF, M., APTE, R. N., KOST, J., and COFIEN, S. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 192–193.
  • Interaction between and targeted liposomes containing linoleic platinum and tumor cell membranes. ZHANG, J., SUN, R. G., SUN, Y. Q., and HAO, A. M. Youji Huaxue, 1995, 15(5), 505–510.
  • Modification of alpha 2-macroglobulin into a macrophage-activating factor through the action of liposome-stimulated B-cell membranous glycosidases. MURAL, M., ARAMAKI, Y., and TSUCHIYA, S. Immunology, 1995, 86 (1), 58–63.
  • Glycoside-bearing liposomal delivery systems against macrophage-associated disorders involving Mycobacterium leprae and Mycobacterium tuberculosis. MEDDA, S., DAS, N., MAHATO, S. B., MAHADEVAN, P. R., and BAsu, M. K., Indian J. Biochem. Biophys., 1995, 32(3), 147–151.
  • Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides. ALVING, C. R., KOULCHIN, V., GLENN, G. M., and RAO, M. Immunol. Rev., 1995, 145 5–31.
  • Effects of alpha-trinositol administered extra- and intracellularly (using liposomes) on rat aorta rings. BRAILOIU, E., BALTATU, 0., COSTULEANU, M., SLATINEANU, S., FILIPEANU, C. M., and BRANISTEANU, D. D. Eur. J. Pharmacol., 1995, 281 (2), 209–212.
  • Intra-arterial liposomal adriamycin for metastatic adenocarcinoma of the liver. KONNO, H., MARCO, Y., MATSUDA, I., NAKAMURA, S., and BABA, S. Eur. Surg. Res., 1995, 27 (5), 301–306.
  • Temperature-induced changes in fluorescence properties as a probe of porphyrin micro-environment in lipid membranes. 1. The partition of hematoporphyrin and proto-porphyrin in liposomes. RICCHELLI, F., GOBBO, S., JORI, G., MORENO, G., and SALET, C. Eur. y. Biocherrz., 1995, 233 (1), 159–164.
  • Efficiency of in vivo gene transfection into transplanted rat heart by coronary infusion of HVJ liposome. SAWA, Y., SUZUKI, K., BA, H. K., SHIRAKUFtA, R., MORISHITA, R., KANEDA, Y., and MATSUDA, H. Circulation, 1995, 92 (9 Suppl), 11479–11482.
  • Solubilizing effects caused by alkyl pyridinium surfactants in phosphatidylcholine liposomes. DE LA MAzA, A., and PARRA, J. L. Chem. Phys. Lipids, 1995, 77 (1), 79–87.
  • Optimization of preparative conditions for polylactide (PLA) microspheres containing oval-bumin. UCHIDA, T., YOSHIDA, K., NINOMIYA, A., and GOTO, S. Chem. Pharm. Bull. (Tokyo), 1995, 43 (9), 1569–1573.
  • Fluorescent vs. radioactive microsphere measurement of regional mycoardial blood flow. CIIIEN, G. L., ANSELONE, C. G., DAVIS, R. F., and VAN WINKLE, D. M. Cardiovasc. Res., 1995, 30 (3), 405–412.
  • Structure of an acidic microcapsular glycan from the reference strain (C.D.C. 866-57) for Serratia marcescens serogroup 01. JOHANSSON, A., WIDMALM, G., JANSSON, P. E., and WILKINSON, S. G. Carbohydr. Res., 1995, 270 (2), 191–199.
  • Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. CAPLEN, N. J., ALTON, E. W., MIDDLETON, P. G., DORIN, J. R., STEVENSON, B. J., GAO, X., DURHAM, S. R., JEFFERY, P. K., HODSON, M. E., COUTELLE, C. et al. Nat. Med., 1995, 1(1), 39–46.
  • Gene therapy for cystic fibrosis in humans by liposome-mediated DNA transfer: the production of resources and the regulatory process. CAPLEN, N. J., GAO, X., HAYES, P., ELASWARAPU, R., FISHER, G., KINRADE, E., CHAKERA, A., SCHORR, J., HUGHES, B., DORIN, J. R. etal. Gene. Ther., 1994, 1(2), 139–147.
  • Mechanistic study on toxicity of positively charged liposomes containing stearylamine to blood. NISHIYA, T., LAM, R. T., ENG, F., ZEREY, M., and LAu, S. Artif. Cells Blood Substit. Biotechnol., 1995, 23 (4), 505–512.
  • Effect of vesicle size on in vivo release of daunorubicin from hydrogenated egg phosphatidyl-choline-based liposomes into blood circulation. NAGAYASU, A., SHIMOOKA, T., and KIWADA, H. Biol. Pharm. Bull., 1995, 18 (7), 1020–1023.
  • Approaches that mitigate doxorubicin-induced delayed adverse effects on mitochondrial function in rat hearts; liposome-encapsulated doxorubicin or combination therapy with antioxidant. SUGIYANIA, S., YANIADA, K., HAYAKAWA, M., and OZAWA, T. Biochem. Mol. Biol. Int., 1995, 36 (5), 1001–1007.
  • Mechanism of liposome destabilization by polycationic amino acids. EPAND, R. M., and LIM, W. Biosci. Rep., 1995, 15 (3), 151–160.
  • Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions. SEAMAN, J., BOER, C. WILKINSON, R., DE JONG, J., DE WILDE, E., SONDORP, E., and DAVIDSON, R. Clin. Infect. Dis., 1995, 21(1), 188–193.
  • Galactose-containing amphiphiles prepared with a lipophilic radical initiator: association processes between liposomes triggered by enzymatic reaction. OHNO, K., SOHDA, K., KOSAKA, A., and KITANO, H. Bioconjug. Chem., 1995, 6 (4), 361–366.
  • Kinetics of Fe2 +-induced lipid peroxidation in liposomes in the presence of ascorbic acid. Concentrated effects of Fe2+ ions. DRENIINA, E. S., and SHAROV, V. S. Biofizika, 1995, 40 (2), 335–341.
  • Reconstitution of membrane proteins into liposomes: application to energy-transducing membrane proteins. RIGAUD, J. L., PITARD, B., and Levy, D. Biochim. Biophys. Acta, 1995, 1231 (3), 223–246.
  • Liposomal amphotericin B in three lung transplant recipients. The Groningen Lung Trans-plantation Group. :MANNES, G. P., VAN DER BI), W., and BOER, W. J. J. Heart Lung Transplant, 1995, 14 (4), 781–784.
  • Liposome fusion induced by a M(r) 18,000 protein localized to the acrosomal region of acrosome-reacted abalone spermatozoa. SWANSON, W. J., and VACQUIER, V. D. Biochemistry, 1995, 34 (43), 14202–14208.
  • Prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin. VAAGE, J., DONOVAN, D., Loe-rus, T., and WORKING, P. Br. J. Cancer, 1995, 72 (5), 1074–1075.
  • Cell cycle-dependent cytotoxicity and induction by apoptosis by liposomal N4-hexadecy1-1-beta-D-arabinofuranosylcytosine. HORBER, D. H., VON BALLMOOS, P., Scnorr, H., and SCHWENDENER, R. A. Br. y. Cancer, 1995, 72(5), 1067–1073.
  • Encapsulation of forscamet in liposomes modifies drug intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution and pharmacokinetics. DUSSERRE, N., LESSARD, C., PAQUETTE, N., PERRON, S., POULIN, L., TREMBLAY, M., BEAUCHAMP, D., DESORMEAUX, A., and BERGERON, M. G. AIDS, 1995, 9(8), 833–841.
  • Pharmacokinetics of ibuprofen following a single administration of a suspension containing enteric-coated microcapsules. WALTER, K., WEISS, G., LAICHER, A., and STANISLAUS, F., Arzneimittelforschung, 1995, 45 (8), 886–890.
  • Pro-oxidant effects of cross-linked haemoglobins explored using liposome and cytochrome C oxidase vesicle model membranes. ROGERS, M. S., PATEL, R. P., REEDER, B. J., SARTI, P., WILSON, M. T., and ALAYASH, A. I.Biochem. y., 1995, 310 (Pt 3), 827–833.
  • Interaction of anionic/nonionic surfactant mixtures with posphatidylcholine liposomes. DE LA MAZA, A., and PARRA, J. L. Arch. Biochem. Biophys., 1995, 322 (1), 167–173.
  • Intracellular accumulation of ofloxacin-loaded liposomes in human synovial fibroblasts. FRESTA, M., SPADARO, A., CERNIGLIA, G., ROPER°, I. M., PUGLISI, G., and FURNIERI, P. M. Antimicrob. Agents Chemother., 1995, 39 (6), 1372–1375.
  • A chloride channel from human placenta reconstituted into giant liposomes. RIQUELNIE, G., STUTZIN, A., BARROS, L. F., and LIBERONA, J. L. Am. J. Obstet. Gynecol., 1995, 173 (3 Pt I), 733–738.
  • Soluble intercellular adhesion molecule-1 and serum cytokines in melanoma patients treated with liposomes containing muramyl tripeptide. FAVARO, D., SANTAROSA, M., QUAIA, M., SPADA, A., FRESCIII, A., TALANIINI, R., and GALLIGIONI, E. Tumori, 1995, 81 (3), 185–190.
  • Apparently successful treatment of two cases of post kala-azar dermal leishmaniasis with liposomal amphotericin B. HASHINI, F. A., KHALIL, E. A., ISMAIL, A., EL HASSAN, A. M. Trans. R. Soc. Trop, Med. Hyg., 1995, 89 (4), 440.
  • The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. RAMPRASAD, M. P., FISCHER, W., WITZTUM, J. L., SAMBRANO, G. R., QUEHENBERGER, 0., and STEINBERG, D. Proc. Natl. Acad. Sci. USA, 1995, 92 (21), 9580–9584.
  • Properties of acetylcholinesterase reconstituted in liposomes of a different charge. Ctio, Y Ko, T. S., CHA, S. H., and SOK, D. E. Neurochem. Res., 1995, 20 (6), 681–687.
  • Cationic liposome-mediated expression of hepatitis C virus genome in adult rat liver. TAKEHARA, AKEHARA., HAYASHI, N., and KAMADA, T. Nippon-Rinsho, 1995, 53 (Suppl), 102–106.
  • Lack of vesicant injury following extravasation of liposomal doxorubicin (letter). MADHAVAN, S., and NORTHFELT, D. W. y. Natl. Cancer Inst., 1995, 87 (20), 1556–1557.
  • Electrical currents generated by a partially purified Na/Ca exchanger from lobster muscle reconstituted into liposomes and adsorbed on black lipid membranes: activation by photolysis of Ca2+. EISENRAUCH, A., JurrAszovA, M., ELLIS DAVIES, G. C., KAPLAN, J. H., BAMBERG, E., and BLAUSTEIN, M. P. J. Membr. Biol., 1995, 145 (2), 151–164.
  • Efficacy of sustained release ciproflaxin microspheres against device-associated Pseudo-monas aeruginosa biofilm infection in a rabbit peritoneal model. Owusu, A. G., ROGERS, J. A., MORCK, D. W., and OLsoN, M. E. y. Med. Microbiol., 1995, 43(5), 368–376.
  • A mechanistic study of the effects of the 1-alkyl-2-pyrrolidones on bilayer permeability of stratum corneum lipid liposomes: a comparison with hairless mouse skin studies. YONETO, K., Li, S. K., GHANENI, A. H., CROMMELIN, D. J., and HIGUCH/, W. 1. J. Pharm. 1995, 84 (7), 853–861.
  • Protein location in liposomes, a drug carrier: a prediction by differential scanning calorimetry. Lo, Y. L., and RAFIMAN, Y. E..7. Pharm. Sci., 1995, 84 (7), 805–814.
  • Basic study and application of functional liposomes. Oxu, N. Yakugaku Zasshi, 1995, 115 (7), 483–498.
  • Tissue distribution of methotrexate following administration as a solution and as a magnetic microsphere conjugate in rats bearing brain tumors. DEVINENI, D., KLEIN, S. A., and GALLO, J. M.j. Neurooncol., 1995, 24 (2), 143–152.
  • Cytotoxic T lymphocyte responses to a liposome-adjuvanted influenza A virus vaccine in the elderly. POWERS, D. C., MANNING, M. C., HANSCOME, P. J., and PIETROBON, P. J., y. Infect. Dis., 1995, 172 (4), 1103–1107.
  • Reconstitution of purified P-glycoprotein into liposomes. NAITO, M., and TSURUO, T..7. Cancer Res. Clin. Oncol., 1995, 121 (9–10), 582–586.
  • Cationic liposome-mediated intravenous gene delivery. Liu, Y., LIGGITT, D., ZHONG, Tu. G., GAENSLER, K., and DEBS, R.5. Biol. Chem., 1995, 270 (42), 24864–24870.
  • Evaluation of new small barium alginate microcapsules. CAPPAI, A., PETRUZZO, P., Rutty, G., CONGIU, T., DESSY, E., DE SETA, W., SANTA CRUZ, G., and BROTZU, G. ha. y. Artif. Organs, 1995, 18 (2), 96–102.
  • Immunogenicity of immunoliposomes: reactivity against species-specific IgG and liposomal phospholipids. PHILLIPS, N. C., and DAHMAN, J. Immunol. Lett., 1995, 45 (3), 149–152.
  • Enhanced adeno-associated virus vector expression by adenovirus protein-cationic liposome complex. A novel and high efficient way to introduce foreign DNA into endothelial cells. ZHOU, H., ZENG, G., ZHU, X., TANG, J., CHEN, G., HUANG, Q., PENG, T., and Hu, B. Chin. Med. y. (Engl), 1995, 108 (5), 332–337.
  • Intravesical liposomal muramyl tripeptide phosphatidylethanolamine treatment of human bladder carcinoma growing in nude mice. DINNEY, C. P., TANGUAY, S., BUCANA, C. D., EVE, B. Y., and FIDLER, I. J..7. Interferon Cytokine Res., 1995, 15 (6), 585–592.
  • Cytokine-containing liposomes as adjuvants for subunit vaccines. LACHMAN, L. B., SHIH, L. C., RAO, AO. M., ULLRICH, S. E., and CLELAND, J. L. Pharm. Biotechnol., 1995,6, 659–671.
  • Design and production of single-immunization vaccines using polylactide polyglycolide microsphere systems. CLELAND, J. L. Pharm. Biotechnol., 1995, 6, 439–462.
  • Polymer microspheres for vaccine delivery. HANES, J., CHIBA, M., and LANCER, R. Pharm. Biotechnol., 1995, 6, 389–412.
  • Liposome design and vaccine development. PIETROBON, P. J. Pharm. Biotechnol., 1995, 6, 347-361. Liposomal presentation of antigens for human vaccines. GLUCK, R. Pharm. Biotechnol., 1995, 6, 325–345.
  • The effect of hyperbarism on the electrical stability and aggregation ability of liposomal membranes. TIURIN, K. A. Aviakosm. Ekolog. Med., 1995, 29 (2), 25–27.
  • Interactions between bacteriohopane-32,33,34,35-tetrol and liposomal membranes composed of dipalrnitoylphosphatidylcholine. CHEN, Z., SATO, Y NAKAZAWA, I., and SUZUKI, Y. Biol. Pharm. Bull., 1995, 18 (3), 477–480.
  • Amphotericin B-availability in the cornea. Studies with local administration of liposome incorporated amphotericin B. PLEYER, U., GRAMMER, J., PLEYER, J. H., KOSMIDIS, P., FRIESS, D., SCHMIDT, K. H., and THIEL, H. J. Ophthalmologe, 1995, 92 (4), 469–475.
  • Targeting HIV with liposome-encapsulated antivirals (editorial). DESORMEAUX, A., and BERGON, G. Int. .y. Med. Microbiol. Viral. Parasitol. Infect. Dis., 1995, 282 (3), 225–231.
  • Pharmacokinetics of methotrexate after intravenous and intramuscular injection of metho-trexate-bearing positively charged liposomes to rats. KIM, NI. M., LEE, S. H., LEE, M. G., HWANG, S. J., and Krm, C. K. Biopharm. Drug Dispos., 1995, 16 (4), 279–293.
  • Surface modifications of alginate/poly(L-lysine) microcapsular membranes with poly(ethylene glycol) and poly(vinyl alcohol). KUNG, I. M., WANG, F. F., CHANG, Y. C., and WANG, Y. J. Biomaterials, 1995, 16 (8), 649–655.
  • Biodistribution of liposome-associated bupivacaine after extradural administration to rabbits. BOOGAERTS, J. G. LAFONT, N. D., CARLING, S., NOEL, E., RAYNAL, P., GOFFINET, G., and LEGROS, F. J. Br.J. Anaesth., 1995, 75 (3), 319–325.
  • Biodistribution of liposome after extradural administration in rodents. UNIBRAIN, V., ALAFANDY, M., BOURGEOIS, P., D'HAESE, J., BOOGAERTS, J. G., GOFFINET, G., CANIU, F., and LEGROS, F. J. Br. y. Anaesth., 1995, 75(3), 311–318.
  • Liposomal local anaesthetics (editorial). DUNCAN, L., and WILDSNIITH, J. A. Br. j. Anaesth., 1995, 75 (3), 260–261.
  • Lymphoid tissues targeting of liposome-encapsulated 2',3'-dideoxyinosine. HARVIE, P., DESORMEAUX, A., GAGNE, N., TREMBLAY, M., POLLEN, L., BEAUCHAMP, D., and BERGERON, M. G. AIDS, 1995, 9 (7), 701–707.
  • Antioxidant protection of egg lecithin liposomes during sonication. GABRIELSKA, J., SARAPUK, J., and PRZESTALSKI, S., Z. Naturforsch. (C), 1995, 50 (7-8), 561–564.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.